Home › Funds › NUANCE INVESTMENTS, LLC › QGEN
NUANCE INVESTMENTS, LLC position in QGEN
QIAGEN NV · Health Care
NUANCE INVESTMENTS, LLC reported holding 1,351,360 shares of QGEN (QIAGEN NV) in its Q3 2026 13F filing — a position valued at US$59.1M, representing 10.86% of its reported portfolio and ranking #1 among its reported holdings. NUANCE INVESTMENTS, LLC has disclosed QGEN holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NUANCE INVESTMENTS, LLC's QGEN position evolved
NUANCE INVESTMENTS, LLC first disclosed a stake in QGEN in Q4 2023 at 1,093,234 shares (US$47.5M). The position peaked in Q2 2024 at 5,271,494 shares, worth US$216.6M. Across 12 filings, NUANCE INVESTMENTS, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,351,360 shares valued at US$59.1M — a reduction of -244,366 shares quarter over quarter.. Notable position changes include a 311% increase in Q1 2024 (shares fell 4% over the following quarter), a 60% trim in Q3 2025 (shares were roughly flat over the following quarter), a 64% increase in Q1 2026 (shares fell 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.09M | $47.48M | New |
| Q1 2024 | 4.49M | $193.18M | Add |
| Q2 2024 | 5.27M | $216.61M | Add |
| Q3 2024 | 4.49M | $204.74M | Reduce |
| Q4 2024 | 4.15M | $184.58M | Reduce |
| Q1 2025 | 2.78M | $111.55M | Reduce |
| Q2 2025 | 1.36M | $65.26M | Reduce |
| Q3 2025 | 538.82K | $24.07M | Reduce |
| Q4 2025 | 803.59K | $36.14M | Add |
| Q1 2026 | 1.32M | $52.86M | Add |
| Q2 2026 | 1.60M | $62.39M | Add |
| Q3 2026 | 1.35M | $59.14M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QGEN and 13F data
QGEN (QIAGEN NV) is a Health Care company. 28 other funds we track also report a position in QGEN — the largest reported positions include Fivespan Partners, LP (US$237.6M), EARNEST PARTNERS LLC (US$203.6M), Helikon Investments Ltd (US$100.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QGEN
- Fivespan Partners, LP 5.43M sh · $237.58M · Q3 2026
- EARNEST PARTNERS LLC 4.65M sh · $203.58M · Q3 2026
- Helikon Investments Ltd 2.29M sh · $100.28M · Q3 2026
More on NUANCE INVESTMENTS, LLC
FAQ
How long has NUANCE INVESTMENTS, LLC held QGEN?
NUANCE INVESTMENTS, LLC has disclosed QGEN holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is NUANCE INVESTMENTS, LLC's current position in QGEN?
As of Q3 2026, NUANCE INVESTMENTS, LLC holds 1.35M shares of QGEN (QIAGEN NV), valued at $59.14M, representing 10.86% of its reported portfolio and ranking #1.
Has NUANCE INVESTMENTS, LLC been buying or selling QGEN?
In the latest 13F filing (Q3 2026), NUANCE INVESTMENTS, LLC reduced its position in QGEN. The position peaked in Q2 2024 at 5.27M shares.
Which other funds hold QGEN?
Other major institutional holders of QGEN include Fivespan Partners, LP, EARNEST PARTNERS LLC, Helikon Investments Ltd, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.